Evans Daron → NEPHROS INC NEPH

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

15,442 shares short · -39.0% vs prior

Other 13D/G Filings on NEPHROS INC

Filed	Form	Filer	Stake	Shares
2026-09-16	SCHEDULE 13D/A	WEXFORD CAPITAL LP	—	223,539	view →
2026-09-16	SCHEDULE 13G	DAVIDSON CHARLES E	—	—	view →
2020-10-26	SC	WEXFORD CAPITAL LP	—	—	view →
2020-10-21	SC	PESSIN NORMAN H	—	—	view →
2019-05-20	SC	PESSIN NORMAN H	—	—	view →
2018-01-12	SC	WEXFORD CAPITAL LP	—	—	view →

Other Filings by Evans Daron

Filed	Form	Issuer	Stake	Shares
2018-01-04	SC	Viking Therapeutics, Inc. VKTX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →